Showing 31 - 40 of 2221 results

Showing Results for: “type diabetes”

Type 1 Diabetes May Affect Brain Development, Beginning in Early Childhood

Children with early-onset type 1 diabetes (T1D) and poor glycemic control have slower growth of areas in the brain associated with mild cognitive deficits compared to children without diabetes, according to the study, “ADA Presidents' Select Abstract: Type 1 Diabetes and the Developing Brain—A Longitudinal Study of Brain Growth by the Diabetes Research in Children Network (DirecNet),” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. The study found that children with early-onset T1D have mild but

Insulin-Producing Beta Cells Are Not Irreversibly Lost in Early Type 2 Diabetes

Pancreatic beta cells that do not produce sufficient insulin in people with type 2 diabetes (T2D) are not permanently damaged during the early stages of the disease and can be restored to normal function through the removal of excess fat in the cells, according to a study entitled “Remission of Type 2 Diabetes for Two Years Is Associated with Full Recovery of Beta-Cell Functional Mass in the Diabetes Remission Clinical Trial (DiRECT)” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions®. More than one-third (36%) of the participants who took part in an

Helping Spanish speakers link type 2 diabetes and heart disease and stroke

The American Heart Association and the American Diabetes Association expand landmark Know Diabetes by Heart™ collaboration with Spanish campaign American Heart Association and American Diabetes Association aims to increase awareness and action among Spanish language-dominant people with type 2 diabetes to underscore the link between type 2 diabetes and heart disease and stroke. The announcement comes during Hispanic Heritage Month (September 15 – October 15). The Spanish-language campaign, found at DiabetesdeCorazon.org , is an extension of the American Heart Association and the American

Latest TEDDY Report Outlines Research on Type 1 Diabetes and Celiac Disease

NIDDK study continues to look at possible factors that lead to the development of the diseases in children New results and information surrounding potential “triggers” of the autoimmune process leading to type 1 diabetes (T1D) and how they interact with genetic factors in children at-risk for developing the disease were highlighted in the “Update from the TEDDY Study” symposium today at the American Diabetes Association’s® (ADA’s) 80th Virtual Scientific Sessions. Similar evidence for celiac disease is also being accumulated through the large international study program. The data The

American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population

National program establishes early care management, technology innovation and large health system engagement as a strategic priority for supporting the 34 million U.S. individuals living with diabetes The American Diabetes Association ® (ADA) and Renalytix (NASDAQ: RNLX) (LSE: RENX) announced today a joint program to improve overall kidney health in patients with type 2 diabetes (T2D) in the United States, which is expected to grow to 60 million individuals by 2060. The program intends to drive early detection and risk informed care delivery to delay disease progression, reduce dialysis starts

Dapagliflozin Reduces Progression of Kidney Disease and Renal Death in People with Type 2 Diabetes

The first sub-analysis of renal data from the Dapagliflozin Effect on Cardiovascular Events Thrombolysis In Myocardial Infarction (DECLARE-TIMI 58) trial indicates that dapagliflozin, an oral sodium glucose cotransporter 2 (SGLT2) inhibitor, reduced the progression of kidney disease or renal death in patients with type 2 diabetes (T2D). The initial results from the trial, the first cardiovascular outcome study to enroll a large cohort of patients with diabetes risk factors for Atherosclerotic Cardiovascular Disease (ASCVD) and a large number of patients with diabetes with known ASCVD, were

Patient Perspective: Living with Type 2 Diabetes and Heart Disease Amid COVID-19

The American Heart Association and the American Diabetes Association share inspiration from patients and need-to-know information from experts As emerging science around COVID-19 highlights elevated danger for people with diabetes, heart disease and stroke 1 , the American Heart Association and the American Diabetes Association urge people living with type 2 diabetes and/or cardiovascular disease to manage their conditions and look for unique opportunities to double-down on their health goals during the pandemic. Brandon Lewis of Dallas lives with diabetes, and now is dealing with being at

ADA/EASD Consensus Update on Management of Hyperglycemia in Type 2 Diabetes – Report Published in Diabetes Care

The American Diabetes Association ® (ADA) and the European Association for the Study of Diabetes (EASD) announced today their new consensus update on management of hyperglycemia in type 2 diabetes. The update has been prepared by an international committee of experts that include John B. Buse, MD, PhD, (University of North Carolina School of Medicine, Chapel Hill, NC); Melanie J. Davies, CBE, MBChB, MD, FRCP, FRCGP, FMedSciat (Leicester Diabetes Centre, Leicester, UK); and their colleagues. It updates the previous 2018 and 2019 consensus reports, and like its predecessors, this new document

Risk of Severe Diabetes Ketoacidosis Spiked Among Pediatric Type 1 Diabetes Patients During the Pandemic

Meta-Analysis Compared Rate of Life-Threatening Diabetes Complication Among Children Prior to and During the COVID-19 Pandemic New data presented at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA) revealed the incidence of severe diabetic ketoacidosis (DKA) among children with type 1 diabetes was significantly higher during the pandemic compared to pre-pandemic. DKA is a serious, life-threatening condition that can lead to diabetic coma or even death. While DKA can happen to anyone with diabetes, it is most common among people with type 1 diabetes. DKA is caused by an

American Diabetes Association Symposium to Bring to Light the Impact of Suicide and Depression on Adolescents with Type 1 Diabetes

RESCUE Advocacy Group to Share Latest Insights on Prevalence and Prevention Strategies A symposium presented by international research group, RESCUE (REducing SuiCide rates amongst individUals with diabEtes) Collaborative Community, will address the ongoing connection between suicide and people with type 1 diabetes, with the goal of highlighting available resources and key takeaways for the field. The symposium comes at a time when adolescents and young adults with type 1 diabetes are 61% more likely to say they feel suicidal than those without diabetes. Suicide and Self-Injury—Unveiling and